NEW YORK, Feb. 27, 2023 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Jounce Therapeutics, Inc. (NASDAQ:JNCE), relating to its proposed merger with Redx Pharma. Click here for more information: https://www.monteverdelaw.com/case/jounce-therapeutics-inc. It is free and there is no cost or obligation to you.
SHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Jounce Therapeutics, Inc. - JNCE
PR Newswire -
Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/Apple%20logo%20on%20store%20front%20by%20frantic00%20via%20iStock.jpg)